1. First-in-human evaluation of an independently developed Chinese robot-assisted system for percutaneous coronary intervention.
- Author
-
Guang-Yao ZHAI, Zheng CHEN, Rui-Fang LIU, Yong-He GUO, Jian-Long WANG, Tie-Nan SUN, Jing XIE, Tao HUANG, and Yu-Jie ZHOU
- Subjects
PERCUTANEOUS coronary intervention ,SURGICAL robots ,DRUG-eluting stents ,ANIMAL experimentation ,SWINE ,MANN Whitney U Test ,TREATMENT effectiveness ,CORONARY artery disease ,DESCRIPTIVE statistics ,COMPUTED tomography ,DATA analysis software ,PATIENT safety - Abstract
BACKGROUND Several studies have proved the safety and feasibility of robot-assisted percutaneous coronary intervention (PCI) in reducing the occupational hazards of interventionists while achieving precision medicine. However, an independently developed robot-assisted system for PCI in China has not yet emerged. This study aimed to evaluate the safety and feasibility of a robot-assisted system for elective PCI in China. METHODS This preclinical trial included 22 experimental pigs and preliminarily supported the safety and feasibility of the ETcath200 robot-assisted system for PCI. Then, eleven patients with coronary heart disease who met the inclusion criteria and had clinical indications for elective PCI were enrolled. PCI was performed using a robot-assisted system. The primary outcomes were clinical success (defined as visual estimated residual stenosis < 30% after PCI and no major adverse cardiovascular events during hospitalization and within 30 days after PCI) and technical success (defined as the ability to use the robot-assisted system to complete PCI successfully without conversion to the traditional manual PCI). RESULTS Eleven patients were included in this clinical trial. A drug-eluting stent with a diameter of 3 mm (interquartile range: 2.75-3.5 mm) and a length of 26 mm (interquartile range: 22-28 mm) was deployed in all patients. The clinical success rate was 100%, with no PCI-related complications and no in-hospital or 30-day major adverse cardiovascular events, and the technical success rate was 100%. CONCLUSIONS The results strongly suggest that the use of the independently developed robot-assisted system in China for elective PCI is feasible, safe, and effective. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF